On December 16, it was reported that the U.S. Department of the Treasury website announced on the 15th local time that President Biden signed a new executive order on the same day, imposing sanctions on 15 entities and 10 individuals from China, Brazil, Colombia, and Mexico, including 4 Chinese companies and 1 individual.
According to the U.S. Department of the Treasury website, the alleged reason for the U.S. sanctions is to combat the abuse and addiction issues of fentanyl and other drugs, and it accuses these companies and individuals of "participating in global illegal drug trade."
The four companies are Wuhan Yuancheng Creative Technology Co., Ltd., Shanghai Xunji Chemical Co., Ltd., Hebei Huanhao Biotechnology Co., Ltd., and Hebei Beijing Tongshang Trading Co., Ltd.
Previously, American politicians and media have continuously hyped up the unfounded claims such as "The main source of fentanyl in the United States is from China" and "The precursor of fentanyl in China flows into the United States through Mexico."
The Chinese Embassy in the United States once published an article titled "Statement by the Spokesperson of the Chinese Embassy in the United States on the Fentanyl Issue" on September 3 this year, stating that drugs are a public nuisance to all mankind. We always maintain a "zero tolerance" attitude towards drug issues and rigorously crack down on all types of drug crimes such as drug production and trafficking.
The news above may be in response to the American plan to sanction Chinese biotechnology companies circulating in the market yesterday afternoon.
Yesterday, the market's response from CXO industries was excessive. Today, it was found to be a false alarm, and today several pharmaceutical companies began to rebound strongly.
In fact, speaking of it, will the USA sanction China's biotechnology industry? If so, what types of companies will be sanctioned? Here domestically...